Cash Flow Statement
Growth Metrics

Mimedx (MDXG) EBT Margin Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,558.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,688.00
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -3,575.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3,575.00
Dec 31, 2025 635.00
Sep 30, 2025 651.00
Jun 30, 2025 -1,343.00
Mar 31, 2025 -370.00
Dec 31, 2024 -392.00
Sep 30, 2024 204.00
Jun 30, 2024 1,533.00
Mar 31, 2024 1,611.00
Dec 31, 2023 277.00
Sep 30, 2023 2,391.00
Jun 30, 2023 2,745.00
Mar 31, 2023 1,506.00
Dec 31, 2022 1,308.00
Sep 30, 2022 -914.00
Jun 30, 2022 -1,354.00
Mar 31, 2022 -382.00
Dec 31, 2021 2,585.00
Sep 30, 2021 2,691.00
Jun 30, 2021 1,311.00
Mar 31, 2021 1,224.00
Dec 31, 2020 -1,618.00
Sep 30, 2020 -4,372.00
Jun 30, 2020 973.00
Mar 31, 2020 -624.00
Dec 31, 2019 -7.00
Sep 30, 2019 1,304.00
Jun 30, 2019 -2,733.00
Mar 31, 2019 -2,352.00
Dec 31, 2018 -3,095.00
Sep 30, 2018 -1,502.00
Jun 30, 2018 -690.00
Mar 31, 2018 -513.00
Dec 31, 2017 3,431.00
Sep 30, 2017 840.00
Jun 30, 2017 276.00
Mar 31, 2017 614.00
Dec 31, 2016 -2,760.00
Sep 30, 2016 -652.00
Jun 30, 2016 -636.00
Mar 31, 2016 -774.00
Dec 31, 2015 309.00
Sep 30, 2015 258.00
Jun 30, 2015 1,394.00
Mar 31, 2015 1,505.00
Dec 31, 2014 1,965.00
Sep 30, 2014 1,272.00
Jun 30, 2014 404.00
Mar 31, 2014 892.00
Dec 31, 2013 737.00
Sep 30, 2013 5,143.00
Jun 30, 2013 963.00
Mar 31, 2013 1,592.00
Dec 31, 2012 8,251.00
Sep 30, 2012 2,900.00
Jun 30, 2012 11,452.00
Mar 31, 2012 29,130.00